Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 86 | SFEBES2022 | Next issue

Society for Endocrinology BES 2022

Harrogate, United Kingdom
14 Nov 2022 - 16 Nov 2022

Card image cap
SfE BES is returning to Harrogate in 2022. Join with endocrine specialists from across the UK and beyond for the Society for Endocrinology's flagship meeting.

Symposia

Drugable hormones and their receptors: past, present and future. Are we running out of targets? Are there more hormones to find?

ea0086s2.1 | Drugable hormones and their receptors: past, present and future. Are we running out of targets? Are there more hormones to find? | SFEBES2022

Therapeutic potential of an old friend – the dichotomy of amylin in physiology and pathophysiology

Lutz Thomas

The mature 37 amino acid peptide amylin is derived from the IAPP (islet amyloid polypeptide) gene and is produced in pancreatic beta-cells and – in much lower amounts – in other tissues, like the stomach, spinal ganglia and in the brain. Amylin is characterized by an interesting dichotomy because amylin has to propensity to aggregate into fibrils in some species, but on the other hand also to the physiological control of metabolism (probably in all species). These di...

ea0086s2.3 | Drugable hormones and their receptors: past, present and future. Are we running out of targets? Are there more hormones to find? | SFEBES2022

Can we drug receptors for microbially-produced metabolic hormones?

Milligan Graeme

Can we drug receptors for microbially-produced metabolic hormones and for what indications? G protein-coupled receptors (GPCRs) have been a major group of druggable cell surface receptors and therapeutics targeting many hormone-activated GPCRs have been developed. A number of products of the processing and metabolism of foodstuffs act in a hormone-like manner and these include both short and medium chain length free fatty acids. Short chain fatty acids produced in large amount...